Published in J Immunol on June 02, 2014
Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function. J Mol Cell Cardiol (2015) 1.54
Novel proresolving and tissue-regenerative resolvin and protectin sulfido-conjugated pathways. FASEB J (2015) 0.98
Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice. FASEB J (2015) 0.90
Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis. JCI Insight (2016) 0.88
Macrophages: Their Emerging Roles in Bone. J Bone Miner Res (2015) 0.88
Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent. Am J Physiol Lung Cell Mol Physiol (2015) 0.86
Modulation of Osteoblastic Cell Efferocytosis by Bone Marrow Macrophages. J Cell Biochem (2016) 0.82
Resolvin D1, resolvin D2 and maresin 1 activate the GSK3β anti-inflammatory axis in TLR4-engaged human monocytes. Innate Immun (2016) 0.78
Juxtacrine interaction of macrophages and bone marrow stromal cells induce interleukin-6 signals and promote cell migration. Bone Res (2015) 0.76
Macrophages and skeletal health. Pharmacol Ther (2017) 0.75
Bone Mass is Compromised by the Chemotherapeutic Trabectedin in Association with Effects on Osteoblasts and Macrophage Efferocytosis. J Bone Miner Res (2017) 0.75
Latest perspectives on macrophages in bone homeostasis. Pflugers Arch (2017) 0.75
Resolvin D1 Increases Mucin Secretion in Cultured Rat Conjunctival Goblet Cells via Multiple Signaling Pathways. Invest Ophthalmol Vis Sci (2017) 0.75
Resolution of inflammation: the beginning programs the end. Nat Immunol (2005) 9.81
TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med (2009) 4.58
Autoimmunity and the clearance of dead cells. Cell (2010) 3.90
Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci U S A (2010) 3.60
Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res (2010) 3.33
Teriparatide and osseous regeneration in the oral cavity. N Engl J Med (2010) 3.08
Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. Blood (2012) 2.37
Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents. Chem Biol (2013) 1.96
Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake. Am J Hematol (2008) 1.71
Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids. Eur J Immunol (2010) 1.70
Resolution phase lipid mediators of inflammation: agonists of resolution. Curr Opin Pharmacol (2013) 1.50
Modulation of macrophage efferocytosis in inflammation. Front Immunol (2011) 1.40
Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre/osteoclasts. J Biol Chem (2007) 1.34
Prostaglandins in bone: bad cop, good cop? Trends Endocrinol Metab (2010) 1.28
Transcriptional and translational regulation of TGF-beta production in response to apoptotic cells. J Immunol (2008) 1.26
Specialized proresolving mediators enhance human B cell differentiation to antibody-secreting cells. J Immunol (2012) 1.20
Osteal macrophages support physiologic skeletal remodeling and anabolic actions of parathyroid hormone in bone. Proc Natl Acad Sci U S A (2014) 1.18
The soluble interleukin-6 receptor is a mediator of hematopoietic and skeletal actions of parathyroid hormone. J Biol Chem (2013) 1.00
Resolvin D1 stimulates efferocytosis through p50/p50-mediated suppression of tumor necrosis factor-α expression. J Cell Sci (2013) 0.91
Dramatic increase in cortical thickness induced by femoral marrow ablation followed by a 3-month treatment with PTH in rats. J Bone Miner Res (2010) 0.84